` Comparison: FDMT vs CANF - Alpha Spread

FDMT
vs
C
CANF

Over the past 12 months, FDMT has significantly outperformed CANF, delivering a return of +51% compared to the CANF's 88% drop.

Start AI Comparison

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
FDMT
CANF
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Smart Verdict is Ready!
See Who Stands Out.
All the numbers, charts, and metrics summarized into one smart verdict.
Stocks Compared:
Show Comparison Results
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

FDMT Intrinsic Value
HIDDEN
Show
CANF Intrinsic Value
HIDDEN
Show
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
4D Molecular Therapeutics Inc
NASDAQ:FDMT
8.97 USD
C
Can Fite Biopharma Ltd
TASE:CANF
701 ILS
No Stocks Selected

Compare the stock's valuation with its competitors.

Select Stocks to Compare
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
FDMT, CANF

FDMT
CANF
Add Stock
Revenue
www.alphaspread.com
No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
4D Molecular Therapeutics Inc
Revenue
C
Can Fite Biopharma Ltd
Revenue

All metrics are calculated based on data from the last 10 years.

No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare

Profitability Comparison

Free Cash Flow
FDMT, CANF

FDMT
CANF
Add Stock
Free Cash Flow
www.alphaspread.com
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
4D Molecular Therapeutics Inc
NASDAQ:FDMT
C
Can Fite Biopharma Ltd
TASE:CANF
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
What is Free Cash Flow?

Gross Margin

FDMT
0%
CANF
0%

Operating Margin

FDMT
-191 982.5%
CANF
-474.5%

Net Margin

FDMT
-174 314.2%
CANF
-464.5%

FCF Margin

FDMT
-154 209.2%
CANF
-304.3%

ROE

FDMT
-45.4%
CANF
-122.2%

ROA

FDMT
-40.7%
CANF
-59.7%

ROIC

FDMT
-218.1%
CANF
-1 974.4%

ROCE

FDMT
-47.9%
CANF
-87.2%

Solvency Comparison

No Stocks Selected

Compare company's equity waterfall with its competitors.

Select Stocks to Compare
Balance Sheet Comparison
No Stocks Selected

Compare company's balance sheet with its competitors.

Select Stocks to Compare

Stocks Performance

Stocks Performance
FDMT, CANF

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
FDMT, CANF

Performance Gap Between FDMT and CANF
HIDDEN
Show

Performance By Year
FDMT, CANF

Loading
FDMT
CANF
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare FDMT to other stocks
Custom
Choose any stock to compare
Unlock Full Access to Alpha Spread
Create Free Account